Search Page

1

Cite

Share

Predictors of readmission and reoperation in patients with colorectal cancer.

Quintana JM, Anton-Ladislao A, Lázaro S, Gonzalez N, Bare M, de Larrea NF, Redondo M, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S; REDISSEC CARESS-CCR (Results and Health Services Research in Colorectal Cancer)- group. Quintana JM, et al. Support Care Cancer. 2020 May;28(5):2339-2350. doi: 10.1007/s00520-019-05050-2. Epub 2019 Sep 4. Support Care Cancer. 2020. PMID: 31485982

Cite

Share

2

Cite

Share

Imaging Mass Spectrometry-Based Lipidomic Approach to Classification of Architectural Features in Nevi.

Garate J, Lage S, Fernández R, Velasco V, Abad B, Asumendi A, Gardeazabal J, Arroyo-Berdugo Y, Rodríguez MÁ, Artola JL, Zabalza I, Ochoa B, Fernández JA, Boyano MD. Garate J, et al. Among authors: zabalza i. J Invest Dermatol. 2019 Sep;139(9):2055-2058.e7. doi: 10.1016/j.jid.2019.01.031. Epub 2019 Mar 13. J Invest Dermatol. 2019. PMID: 30878679 Free article. No abstract available.

Cite

Share

3

Cite

Share

Risk scores to predict mortality 2 and 5 years after surgery for colorectal cancer in elderly patients.

González N, Loroño A, Aguirre U, Lázaro S, Baré M, Redondo M, Briones E, Sarasqueta C, Bilbao A, de Larrea NF, Quintana JM; REDISSEC-CARESS/CCR group. González N, et al. World J Surg Oncol. 2021 Aug 26;19(1):252. doi: 10.1186/s12957-021-02356-6. World J Surg Oncol. 2021. PMID: 34446044 Free PMC article.

Cite

Share

4

Cite

Share

A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.

Domenici G, Aurrekoetxea-Rodríguez I, Simões BM, Rábano M, Lee SY, Millán JS, Comaills V, Oliemuller E, López-Ruiz JA, Zabalza I, Howard BA, Kypta RM, Vivanco MD. Domenici G, et al. Among authors: zabalza i. Oncogene. 2019 Apr;38(17):3151-3169. doi: 10.1038/s41388-018-0656-7. Epub 2019 Jan 8. Oncogene. 2019. PMID: 30622340 Free PMC article.

Cite

Share

5

Cite

Share

Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.

Gorroño-Etxebarria I, Aguirre U, Sanchez S, González N, Escobar A, Zabalza I, Quintana JM, Vivanco MD, Waxman J, Kypta RM. Gorroño-Etxebarria I, et al. Among authors: zabalza i. Cancers (Basel). 2019 Jun 28;11(7):908. doi: 10.3390/cancers11070908. Cancers (Basel). 2019. PMID: 31261741 Free PMC article.

Cite

Share

6

Cite

Share

In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer.

Mazo C, Orue-Etxebarria E, Zabalza I, Vivanco MDM, Kypta RM, Beristain A. Mazo C, et al. Among authors: zabalza i. Cancers (Basel). 2018 Dec 15;10(12):517. doi: 10.3390/cancers10120517. Cancers (Basel). 2018. PMID: 30558303 Free PMC article.

Cite

Share

7

Cite

Share

Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.

Santoni M, Monteiro FSM, Massari F, Abahssain H, Aurilio G, Molina-Cerrillo J, Myint ZW, Zabalza IO, Battelli N, Grande E. Santoni M, et al. Among authors: zabalza io. Crit Rev Oncol Hematol. 2022 Jun 17;176:103731. doi: 10.1016/j.critrevonc.2022.103731. Online ahead of print. Crit Rev Oncol Hematol. 2022. PMID: 35718065 Review.

Cite

Share

8

Cite

Share

Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.

Manterola L, Aguirre P, Larrea E, Arestín M, Gaafar A, Elorriaga K, Goicoechea I, Armesto M, Fernández-Mercado M, Zabalza I, López-Duque JC, Larruskain E, Sistiaga JA, Landa M, Zabala A, Santaolalla F, Municio JA, Ispizua Á, García-Pedrero JM, Rodrigo JP, Lawrie CH. Manterola L, et al. Among authors: zabalza i. Sci Rep. 2018 Apr 26;8(1):6613. doi: 10.1038/s41598-018-24780-7. Sci Rep. 2018. PMID: 29700339 Free PMC article.

Cite

Share

9

Cite

Share

Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.

Al Shareef Z, Kardooni H, Murillo-Garzón V, Domenici G, Stylianakis E, Steel JH, Rabano M, Gorroño-Etxebarria I, Zabalza I, Vivanco MD, Waxman J, Kypta RM. Al Shareef Z, et al. Among authors: zabalza i. Oncogene. 2018 Sep;37(39):5305-5324. doi: 10.1038/s41388-018-0294-0. Epub 2018 Jun 1. Oncogene. 2018. PMID: 29858602 Free PMC article.

Cite

Share

10

Cite

Share

Sox2 promotes tamoxifen resistance in breast cancer cells.

Piva M, Domenici G, Iriondo O, Rábano M, Simões BM, Comaills V, Barredo I, López-Ruiz JA, Zabalza I, Kypta R, Vivanco Md. Piva M, et al. Among authors: zabalza i. EMBO Mol Med. 2014 Jan;6(1):66-79. doi: 10.1002/emmm.201303411. EMBO Mol Med. 2014. PMID: 24178749 Free PMC article.

Cite

Share